Regular Aspirin Use May Reduce Risk of Bile Duct Cancer
Researchers have more evidence to promote aspirin as a multi-use medication thanks to a recent study on bile duct cancer. A team at the Mayo Clinic College of Medicine in Rochester, MN studied the aspirin use of 2,395 patients diagnosed with bile duct cancer and 4,769 healthy patients.
After assessing the patients’ use over a 14-year period, researchers concluded that patients who used aspirin were 2.7-3.6 times less likely to develop bile duct cancer. Upon studying the patients with bile duct cancer, 24.7 percent used aspirin, while 44.6 percent of healthy patients were regular aspirin users.
An additional discovery in this study was the designation of three distinct subtypes of bile duct cancer as distinct diseases. Researchers found that each subtype had distinctly different risk factors; however, one of the most well-known risk factors is chronic and persistent inflammation of the bile ducts. Researchers believe aspirin, with its anti-inflammatory properties, works to reduce cancer risk.
Many Americans use aspirin both as a preventative measure as well as to help with a variety of ailments. Doctors also put many older Americans on a daily aspirin regimen to help prevent blood clot formation and reduce their risk of heart attack and stroke. A quick application of aspirin to a patient who has just suffered a heart attack can also help reduce cardiac tissue death or recurrence of a heart attack.
Bile Duct Cancer is Rare but Causes Disability Quickly
According to the American Cancer Society, bile duct cancer only occurs in about 2,000-3,000 people per year. However, once diagnosed, the disease progresses quickly, with a five-year survival rate of only 15 to 30 percent. If you can no longer work due to the effects of cancer, contact the Disability Help Group at 800-800-2009 to schedule a consultation with one of our disability advocates.